Luis Ostrosky‐Zeichner
Impact in
- Infectious Diseases top 0.01%
- Antifungal resistance and susceptibility
-
- Antibiotic Use and Resistance
Papers in
-
- Antifungal resistance and susceptibility 140
- Antimicrobial Resistance in Staphylococcus 12
- Epidemiology 100
- Fungal Infections and Studies 74
- Nail Diseases and Treatments 23
- Pneumocystis jirovecii pneumonia detection and treatment 13
- Co-authors
- Peter G. Pappas (27 shared papers)John Rex (33 shared papers)Thomas J. Walsh (16 shared papers)David R. Andes (13 shared papers)Carol A. Kauffman (7 shared papers)Annette C. Reboli (8 shared papers)José A. Vázquez (16 shared papers)Bart Jan Kullberg (8 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (24 papers)Open Forum Infectious Diseases (22 papers)Clinical Infectious Diseases (21 papers)Journal of Clinical Microbiology (14 papers)Mycoses (8 papers)
- Partner nations
- United StatesUnited KingdomMexico
In The Last Decade
Luis Ostrosky‐Zeichner
207 papers receiving 17.7k citations
Luis Ostrosky‐Zeichner's Hit Papers
Peers
Comparison fields: 5 of 162
- Infectious Diseases 13.4k
- Applied Microbiology and Biotechnology 826
- Epidemiology 9.1k
- Clinical Biochemistry 747
- Small Animals 836
Countries citing papers authored by Luis Ostrosky‐Zeichner
This map shows the geographic impact of Luis Ostrosky‐Zeichner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Ostrosky‐Zeichner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Ostrosky‐Zeichner more than expected).
Fields of papers citing papers by Luis Ostrosky‐Zeichner
This network shows the impact of papers produced by Luis Ostrosky‐Zeichner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Ostrosky‐Zeichner. The network helps show where Luis Ostrosky‐Zeichner may publish in the future.
Co-authors
The 25 scholars most cited alongside Luis Ostrosky‐Zeichner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 215 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America Hit paper breakdown → | 2015 | 2718 |
| 2 | Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America Hit paper breakdown → | 2009 | 2335 |
| 3 | Invasive candidiasis Hit paper breakdown → | 2018 | 1059 |
| 4 | Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America Hit paper breakdown → | 2016 | 985 |
| 5 | Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial Hit paper breakdown → | 2007 | 515 |
| 6 | 2005 | 499 | |
| 7 | 2004 | 478 | |
| 8 | Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis Hit paper breakdown → | 2007 | 477 |
| 9 | 2004 | 444 | |
| 10 | 2003 | 411 | |
| 11 | 2010 | 339 | |
| 12 | 2003 | 315 | |
| 13 | T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial Hit paper breakdown → | 2015 | 300 |
| 14 | 2007 | 278 | |
| 15 | 2020 | 236 | |
| 16 | 2003 | 214 | |
| 17 | 2008 | 200 | |
| 18 | 2006 | 180 | |
| 19 | 2005 | 150 | |
| 20 | 2011 | 148 |
About Luis Ostrosky‐Zeichner
Luis Ostrosky‐Zeichner is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Small Animals and Pulmonary and Respiratory Medicine, having authored 215 papers that have together received 18.1k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (140 papers), Fungal Infections and Studies (74 papers), Nail Diseases and Treatments (23 papers), Infectious Diseases and Mycology (16 papers), Antibiotic Use and Resistance (15 papers), Pneumocystis jirovecii pneumonia detection and treatment (13 papers), Antimicrobial Resistance in Staphylococcus (12 papers) and Nosocomial Infections in ICU (11 papers). The work is most often cited by research in Infectious Diseases (13.4k citations), Applied Microbiology and Biotechnology (826 citations), Epidemiology (9.1k citations), Clinical Biochemistry (747 citations) and Small Animals (836 citations). Luis Ostrosky‐Zeichner has collaborated with scholars based in United States, United Kingdom and Mexico. Frequent co-authors include Peter G. Pappas, John Rex, Thomas J. Walsh, David R. Andes, Carol A. Kauffman, Annette C. Reboli, José A. Vázquez, Bart Jan Kullberg, Kieren A. Marr and Cornelius J. Clancy. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Open Forum Infectious Diseases, Clinical Infectious Diseases, Journal of Clinical Microbiology and Mycoses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.